Industry News
Pharmaceutical Industry News
Asia-Pacific Countries Rush to Buy Merck Covid Pill
The home treatment, molnupiravir, is said by the company to potentially halve the risk of hospitalization and death from the virus.
Moderna to pour $500M into Africa to meet future mRNA vaccine manufacturing demand
Moderna to pour $500M into Africa to meet future mRNA vaccine manufacturing demand jkeenan Thu, 10/07/2021 - 08:33
Merck’s molnupiravir will be a blockbuster drug during pandemic. What about endemic COVID-19?
Merck's molnupiravir will be a blockbuster drug during pandemic. What about endemic COVID-19? aliu Thu, 10/07/2021 - 08:14
The State of the Pandemic
What can the U.S. expect from the coronavirus this fall? And what do we know about booster shots and a possible new treatment?
Pilot launch complete: GlaxoSmithKline’s malaria shot scores WHO backing for wider rollout in Africa
Pilot launch complete: GlaxoSmithKline's malaria shot scores WHO backing for wider rollout in Africa esagonowsky Wed, 10/06/2021 - 14:14
Biogen, mRNA players on Merck’s M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT
Biogen, mRNA players on Merck's M&A radar as CEO still hungry for deals after $11.5B Acceleron buy: FT aliu Wed, 10/06/2021 - 11:31
Buyers clamor for Merck’s COVID-19 antiviral molnupiravir, but pricing is already controversial
Buyers clamor for Merck's COVID-19 antiviral molnupiravir, but pricing is already controversial kdunleavy Wed, 10/06/2021 - 10:23
With D.C. drug pricing talks up in the air, the ‘endgame’ could still ‘have a bite,’ analyst says
With D.C. drug pricing talks up in the air, the 'endgame' could still 'have a bite,' analyst says esagonowsky Wed, 10/06/2021 - 09:58
NICE backs Novartis’ Adakveo via special channel despite ‘high uncertainty’ about cost, long-term efficacy
NICE backs Novartis' Adakveo via special channel despite 'high uncertainty' about cost, long-term efficacy aliu Wed, 10/06/2021 - 09:23
Cancer survivors fear lymphedema. ImpediMed’s campaigning for testing that can prevent it
Cancer survivors fear lymphedema. ImpediMed's campaigning for testing that can prevent it nmissakian Tue, 10/05/2021 - 17:29
Biohaven’s Nurtec, with dual migraine approvals, hits $136M in quarterly sales and leads the pack in market share
Biohaven's Nurtec, with dual migraine approvals, hits $136M in quarterly sales and leads the pack in market share esagonowsky Tue, 10/05/2021 - 10:36
GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs
GlaxoSmithKline relocates U.S. operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs aliu Tue, 10/05/2021 - 10:34
GlaxoSmithKline relocates US operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs
GlaxoSmithKline relocates US operations in Philadelphia, North Carolina as COVID-19 cuts its office space needs aliu Tue, 10/05/2021 - 10:34
Bayer pledges $464M to upgrade, build production facilities in contraceptives push
Bayer pledges $464M to upgrade, build production facilities in contraceptives push jkeenan Tue, 10/05/2021 - 09:45
As Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringement
As Revance nears a potential launch for its Botox rival, AbbVie sues for patent infringement esagonowsky Tue, 10/05/2021 - 09:32
Cambrex to pump $30M into expanding North Carolina manufacturing site
Cambrex to pump $30M into expanding North Carolina manufacturing site jkeenan Tue, 10/05/2021 - 08:40
Merck and Ridgeback’s molnupiravir will be ‘complementary, but not a competitor’ to COVID-19 vaccines: analyst
Merck and Ridgeback's molnupiravir will be 'complementary, but not a competitor' to COVID-19 vaccines: analyst kdunleavy Tue, 10/05/2021 - 07:45
‘Pharma Bro’ Review: Behind the Smirk
This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests.
Gates Foundation backs Nanoform’s work to improve drug access
Gates Foundation backs Nanoform's work to improve drug access ntaylor Tue, 10/05/2021 - 04:51
Syros starts study to drive IV to oral switch in leukemia
Syros starts study to drive IV to oral switch in leukemia ntaylor Tue, 10/05/2021 - 04:47